Munich, October 27, 2014 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of a new open access journal Biomolecular Detection and Quantification - BDQ.
Published quarterly online and open access, BDQ is dedicated to championing excellence in molecular biology-based study design, measurement, data analyses and reporting. The journal includes qualitative and quantitative studies in clinical and life sciences that adhere to best-practice guidelines, publishing original research papers, review articles, short communications, commentaries, points of view, and perspective articles.
Founding editors of the journal are the molecular methodology pioneers, Professor Carl Wittwer, University of Utah, Michael Pfaffl, Technical University Munich and Ron Cook, Bio Research Tech UK. They will be joined by Editor-in-Chief Stephen Bustin, Managing Editors Jim Huggett and Justin O'Grady, and an Editorial Board of experienced scientists from around the world.
BDQ will cover both clinical subjects such as epigenetics, gene expression, and diagnostics and non-clinical subjects, including industrial microbiology and environmental and food science.
Editor-in-Chief Stephen Bustin commented, "Biomolecular Detection and Quantification offers a unique open access publication that encourages the reporting and sharing of technical experiences from all life science and clinical specialties. The journal's mission is to improve molecular measurement to ensure findings are correctly interpreted and reproducible. The editorial team and I are very excited about being part of this opportunity to support excellence in Biomolecular Detection and Quantification."
Helen Habernickel, Publisher at Elsevier said, "BDQ will serve as forum for sharing key findings across what may otherwise be disparate specialties. We are happy to support the research community by making the journal's content as widely available as possible."
First published papers are now available online on ScienceDirect: http://www.
For more information or to submit an article, go to http://www.
About Open Access Publishing at Elsevier
Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as over 100 open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit http://www.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey -- and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).